tanshinone has been researched along with thioguanine anhydrous in 1 studies
| Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (thioguanine anhydrous) | Trials (thioguanine anhydrous) | Recent Studies (post-2010) (thioguanine anhydrous) |
|---|---|---|---|---|---|
| 1,445 | 10 | 1,033 | 2,706 | 295 | 389 |
| Protein | Taxonomy | tanshinone (IC50) | thioguanine anhydrous (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.5333 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.601 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 5.516 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, Y; Jadhav, P; Tan, B; Tan, H; Wang, J | 1 |
1 review(s) available for tanshinone and thioguanine anhydrous
| Article | Year |
|---|---|
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.
Topics: Antiviral Agents; Coronavirus Papain-Like Proteases; COVID-19 Drug Treatment; Humans; Pandemics; Protease Inhibitors; SARS-CoV-2 | 2022 |